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In infants, hematochezia must be approached with a broad differential diagnosis, including anal ﬁssure,
allergic colitis, Meckel’s diverticulum, intestinal malrotation, necrotizing enterocolitis, and less
commonly arteriovenous malformations, gastrointestinal duplications, and hemangiomas. Infantile
hemangiomas, the most common tumor of infancy, are typically cutaneous lesions. Those arising from
viscera are much less common but can cause signiﬁcant morbidity and mortality if not diagnosed early
and managed appropriately. We present a 6-week-old male with recurrent hematochezia who was
initially diagnosed with milk protein intolerance but ultimately found to have a diffuse intestinal
hemangioma. He was treated with propranolol, methylprednisolone, and exclusively parenteral nutri-
tion. Repeat imaging suggested the lesion responded to pharmacotherapy and the patient is tolerating
enteral nutrition.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Gastrointestinal bleeding is a major cause of morbidity and
mortality in children. The epidemiology of lower gastrointestinal
bleeding in children is not known. In one study, out of 40,000patient
visits to a pediatric emergency department, rectal bleeding was the
chief complaint of 0.3 percent of the cases [1]. Some of the most
common causes of hematochezia are analﬁssure, allergic colitis, and
Meckel’s diverticulum. Less common etiologies, but important to
consider, include gastrointestinal duplications, Dieulafoy lesions,
arteriovenous malformations, and hemangiomas. Determining the
cause of hematochezia can be challenging, especially if it is due to
one of the rare causes. Hemangiomas of the gastrointestinal tract are
rare andestimated to account for 0.05% of intestinal neoplasms,with
the most common site being the small intestines, speciﬁcally the
jejunum and ileum [2,3]. Patients with GI hemangiomas typically
present within the ﬁrst 4 months of life with melena or hema-
tochezia [3], abdominal pain, anemia, and occasionally intussus-
ception, obstruction [4], or intestinal perforation [3,5].0 N. Academy Ave., Danville,
is).
Inc. This is an open access article u1. Case report
We present a 6-week-old male, born at 35 weeks gestational
age. He was on breast milk, reached his birth weight at the time of
presentation, and typically had loose, brown stools every 1e2 days.
One day prior to admission, he had 3 episodes of bright red blood
per rectum. He was acting weak, tired, and had minimal non-
bloody non-bilious spit up with feeds. Pertinent review of systems
was negative for fever, abdominal distention, hematemesis, or
melena. On exam, he was afebrile and hemodynamically stable; he
was small, malnourished, and fussy. His abdominal exam was un-
remarkable, rectal exam demonstrated normal tone, no ﬁssures,
tags, or ﬁstulas, guaiac positive.
Labs revealed hemoglobin 6.0 g/dL, mild leukocytosis and
thrombocytosis, lactate 5.3, normal coagulation studies, normal ESR
and CRP, and negative stool cultures. A technetium-99m pertech-
netate (Meckel) scan was negative, barium enema was not sug-
gestive of Hirschsprung’s disease, and abdominal ultrasound was
not suggestive of intussusception. However, the abdominal ultra-
sound was signiﬁcant for counter clockwise rotation of the superior
mesenteric vein with associated dilation and surrounding echo-
genic mesentery. A single contrast barium upper gastrointestinal
series revealed anterior positioning of the proximal duodenum but
normal location of the ligament of Treitz, making the studynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Intraoperative photo of diffusely edematous small bowel covered by
hemangioma.
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low, as it typically does not present with hematochezia that leads to
severe anemia, and given the strong family history of atopy, the
patient was started on Neocate for presumed allergic colitis. His
bowel movements improved and he began gaining weight appro-
priately. He was discharged, with hemoglobin 10.3 g/dL, but was
readmitted seven days later with recurrent hematochezia and
anemia (hemoglobin 6.3 g/dL). An abdominal MRI with andwithout
contrast was completed on this admission, and showed an
enhancing, inﬁltrating mesenteric mass with mass effect on the
transverse colon and displacement of small bowel (Fig. 1). The in-
fant was taken to the operating room and on exploratory laparot-
omy, diffusely edematous small bowl completely covered by what
appeared to be a hemangioma versus arteriovenous malformation
was found and biopsied (Fig. 2). Pathology revealed benign capillary
hemangioma with diffuse GLUT1 positivity (Fig. 3) and focal areas
of extension through the small intestinal wall, reaching peri-
intestinal soft tissue.
Oral feeds were attempted and resulted in increased melenic
stools, he was made nil per os, started on total parenteral nutrition,
propranolol 1 mg/kg per dose twice a day, and methylprednisolone
0.5 mg/kg per dose twice a day. Two months later, CT imaging
suggested response to pharmacotherapy with improvement
compared to initial MRI. He was restarted on oral Pedialyte at about
5 and a half months of age and steroids were weaned off. At the age
of 12 months, regular diet was introduced and was well tolerated,
while the patient was gradually weaned off Neocate Junior. At the
age of 17 months, he is on full oral feeds, and total parenteral
nutrition was stopped. He continues on propranolol daily with no
further episodes of hematochezia.2. Discussion
Infantile hemangiomas are benign vascular tumors and have a
female to male predominance of two to ﬁve to one [6]. Intestinal
hemangiomas are rare, and typically represented only by caseFig. 1. MRI with and without contrast of abdomen showing enhancing inﬁltrating
mesenteric mass with mass effect on the transverse colon and displacement of small
bowel.reports or series in the literature. If cutaneous lesions are present,
especially if more than ﬁve lesions, there is an increased suspicion
of the presence of a visceral lesion, with most common site being
the liver [7]. Interestingly, this patient was male and did not have
any cutaneous lesions.
Determining the source of hematochezia continues to be a
diagnostic challenge. Some cases have been paired ultrasound
and CT scan [4], used laparoscopy [8], or used scintigraphy with
technetium-99m-labeled red blood cells and angiography [9] to
identify the source of hematochezia as a gastrointestinal heman-
gioma. We used a combination of different imaging modalities,
primarily ultrasound and MRI, which prompted exploratory lapa-
rotomy and therefore leading to the diagnosis. Soukoulis et al.Fig. 3. Small intestine biopsy specimen showing diffuse GLUT1 (glucose transporter 1)
positivity.
G.A. Morris et al. / J Ped Surg Case Reports 3 (2015) 280e282282found there is often dilation of the superior mesenteric artery and
vein in patients with hollow visceral GI hemangiomas, which our
patient also had on ultrasound [3]. This may be due to increased
blood ﬂow to the tumor through feeder vessels. This case further
supports high-resolution ultrasonography as the ﬁrst line imaging
when concerned for possible GI hemangioma.
Based on the radiographic ﬁndings, the patient underwent an
exploratory laparotomy. Intraoperatively, on gross appearance the
lesion appeared to be a hemangioma verses an arteriovenous
malformation. Pathology revealed diffuse GLUT1 positivity. GLUT1
is an erythrocyte-type glucose transporter protein expressed in the
endothelium of tissues. GLUT1 has been identiﬁed to distinguish
infantile hemangioma from capillary proliferation in other vascular
malformations [10].
The majority of children with infantile hemangiomas have a
benign and uncomplicated course. However, there are certain in-
dications for treatment, including functional impairment of
vital organs or ulceration [11]. When necessary, propranolol, a non-
selective beta-blocker, has become the ﬁrst line treatment for in-
fantile hemangiomas. The mechanism of action is not completely
clear; however its effects can be divided into early, intermediate,
and late effects [11]. The early effects of propranolol include vaso-
constriction from decreasing the release of nitric oxide. Vascular
endothelial growth factor and other angiogenic factors are blocked
as part of the intermediate effects. Finally, apoptosis is induced in
the proliferating capillary endothelial cells causing tumor regres-
sion as the long-term effects of the medication. The indication for
corticosteroid therapy includes life-threatening infantile heman-
gioma or large hemangiomas [12]. The mechanism of action of
corticosteroids is not entirely understood, but may be related to
decreasing angiogenesis by inhibiting vascular endothelial growth
factor and vasoconstriction.
This patient had a CT scan about two months after presentation
which suggested response to pharmacotherapy compared to initial
MRI. However, it was somewhat difﬁcult to separate collapsed
bowel loops from the mass. Therefore, MRI would be the preferred
imaging for any additional follow-up as it could be used as direct
comparison with the initial scan. There are no clinical guidelines
that establish when, or if, to obtain follow-up imaging. Clinical
judgment is used to determine the duration of therapy and should
also dictate any plans for follow-up imaging.
3. Conclusion
Visceral vascular anomalies are a diagnostic challenge in the
pediatric population. In the presence of dramatic drop in thehemoglobin and presence of hematochezia, it is recommended to
consider this vascular anomaly in the differential diagnosis, as
treatment options are drastically different. This patient’s initial
diagnostic work up was inconclusive. However, imaging and his-
tological evidence were paired to make the diagnosis, and subse-
quently initiate appropriate treatment. This case is unusual
because, retrospectively, imaging was suggestive of malrotation;
however, MRI was consistent with an inﬁltrating mesenteric mass
that histologically was conﬁrmed to be an intestinal hemangioma.
Early recognition and treatment of this pathology may result in
prompt initiation of medical treatment, resolution of symptoms,
gradual advancement of enteral nutrition, and improvement of
quality of life for the patient and family.
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